Seminars in Oncology
Volume 38, Issue 3 , Pages 413-423, June 2011

Essential Drugs in Supportive Care

  • Bassam Estfan

      Affiliations

    • Corresponding Author InformationAddress correspondence to Bassam Estfan, MD, 9500 Euclid Ave, R35, Cleveland, OH 44195

Cleveland Clinic, Taussig Cancer Institute, Department of Solid Tumor Oncology, Cleveland, OH

Progress in cancer treatment has brought with it challenges that go beyond cure. Toxicities and morbidity are among the biggest hurdles for a cancer patient to face while hoping for the end of chemotherapy or radiation therapy. Important advances have been made in the science of supportive care to address cancer treatment toxicities and complications. Nausea and vomiting, bone complications, hot flashes, and bone marrow failure are some areas where a huge impact has been made on quality of life and treatment experience. Complications that remain without good remedies await a better understanding of new targets and drugs.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Financial disclosures: none.

PII: S0093-7754(11)00082-0

doi:10.1053/j.seminoncol.2011.03.012

Seminars in Oncology
Volume 38, Issue 3 , Pages 413-423, June 2011